Which is the best site to inject tirzepatide, and does it matter?

Tirzepatide has three licensed subcutaneous injection sites: abdomen, front of thigh, and outer upper arm, each equally valid when used correctly.
Rotating sites every week prevents localised skin thickening (lipohypertrophy), which can impair how the medicine is absorbed.
The abdomen tends to offer the largest, easiest-to-access surface area for most people, making it a common starting point.
Never inject into skin that is bruised, scarred, tattooed, or irritated, pick an alternative spot and return to the rotation.

The three licensed injection sites for tirzepatide are the abdomen, the front of the thigh, and the outer upper arm. Rotating between them each week reduces the risk of skin changes at any single spot and keeps absorption consistent. Choosing the right site — and using it correctly — is one of the small habits that makes a real difference to how well your treatment works. Tirzepatide (sold in the UK as Mounjaro) is a prescription-only medicine; a GPhC-registered prescriber reviews your suitability before any treatment begins, and your Patient Information Leaflet is the definitive guide for your specific situation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Everything you need to know about tirzepatide injection sites, technique, and rotation

Where exactly on the body can you inject tirzepatide?

The licensed sites are the abdomen (belly), the front of the thigh, and the outer upper arm. Within each area you have more room than you might expect. On the abdomen, aim for the soft tissue a few centimetres away from the navel, not directly on it, and not on the belt line where clothing can rub. The front and outer side of the thigh (roughly mid-thigh) works well whether you are sitting or standing. The outer upper arm is perfectly usable, though some people find it easier to have a partner or family member help with that site, since the angle can be awkward to manage solo.

Subcutaneous means just beneath the skin, into the fatty tissue, not into muscle. The Mounjaro KwikPen is designed to deliver the dose at the correct depth automatically, so you do not need to pinch the skin or vary your angle as you might with older insulin-style injections. For a step-by-step walkthrough of the full injection process, the guide to injecting tirzepatide covers needle attachment, priming and disposal in detail.

If you are curious about whether one site produces noticeably different results from another, the comparison of injection locations for tirzepatide goes into that question specifically.

Why does rotation matter more than most people realise?

Injecting repeatedly into the same small patch of skin causes the fatty tissue to change texture, a condition called lipohypertrophy. The skin can feel lumpy or harder than usual. Medicine injected into those areas is absorbed unevenly and more slowly, which can blunt the effect of your dose and make nausea and other side effects less predictable. Rotating between all three sites, and moving around within each site, keeps the tissue healthy.

A practical system: many people use the abdomen for the first week, the left thigh the second, the right thigh the third, and the upper arm the fourth. Others rotate left-to-right within the abdomen each time. There is no single required pattern, the goal is simply never returning to the same small area two weeks running. Some people pencil the site in their phone calendar alongside their injection day reminder. A simple tracker, whatever form it takes, removes the guesswork.

The Mounjaro-specific injection site guide has worked examples of rotation schedules if you prefer something more structured. And if you are thinking about timing your injection for a particular day of the week, the guidance on the best time to inject tirzepatide is worth reading alongside this page.

Are there sites to avoid, and what about technique details?

Yes. Avoid areas where the skin is bruised, actively irritated, scarred from surgery, or affected by a skin condition. Tattoos are generally avoided too, not for any pharmacological reason, but because it can make injection-site reactions harder to spot. Waistbands and trouser lines are worth avoiding on abdominal injections because friction can increase local irritation after the injection.

Clean the chosen area with an alcohol swab and allow it to dry fully before injecting. Wet skin can sting more and, in theory, carry surface bacteria into the puncture site. Medical-grade alcohol swabs are stocked by nume's pharmacy if you need a reliable supply. Press the pen firmly against the skin and hold it there for the full count after the click, your leaflet specifies the exact hold time, and it is longer than many people initially expect. Do not rub the site afterwards.

Used pens must be disposed of safely. A 1-litre sharps container keeps them contained until your local pharmacy or household waste service can collect them, never put used pens in general household bins.

The NHS tirzepatide patient page has further practical guidance on how to use tirzepatide safely, and is worth bookmarking alongside your Patient Information Leaflet.

What if you have a specific concern about your injection site?

Occasional mild redness or a small welt at the injection site is common, particularly in the first few weeks. It usually settles within a day or two and is not a reason to stop. Persistent pain, a growing lump, widespread redness, or a firm area that does not resolve after a fortnight all warrant a conversation with your prescriber.

Some people notice that side effects such as nausea seem more pronounced after switching sites. The connection between injection location and absorption rate is real but small at population level; individual variation is wider. If you are finding the side-effect pattern disruptive, that is exactly the sort of thing to raise with your clinical team rather than adjusting things yourself.

Understanding cost is a reasonable part of planning treatment, and the context around Mounjaro pricing in the UK is a useful reference. For a broader look at the treatment itself, the Mounjaro overview explains the full picture, including how the dual GIP and GLP-1 mechanism differs from other weight-loss medicines. When you are ready to talk through your situation with a real prescriber, starting a free consultation with our clinical team is the next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions